Skip Navigation


NDT Advance Access originally published online on March 4, 2009
Nephrology Dialysis Transplantation 2009 24(6):1724-1726; doi:10.1093/ndt/gfp100
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/6/1724    most recent
gfp100v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Levin, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levin, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Predicting outcomes in CKD: the importance of perspectives, populations and practices

Adeera Levin, MD, FRCPC

Division of Nephrology, University of British Columbia, Vancouver, Canada

Correspondence and offprint requests to: Adeera Levin, MD, FRCPC; E-mail: alevin@providencehealth.bc.ca

Keywords: eGFR; elderly populations; epidemiology; health care systems; outcomes

The first 150 words of the full text of this article appear below.

The problem of chronic kidney disease (CKD) has been brought into focus over the last 7 years since the publication and dissemination of the KDOQI definition, evaluation and classification of CKD guidelines, and the implementation of eGFR reporting by laboratories in numerous jurisdictions [1]. Together these two ‘events’ have substantially increased awareness about and focus on CKD in both clinical and academic spheres. Concerns and issues have been raised as to the validity of the stages in all populations, the need for more refinement and the possibility of misclassification and inflated estimates of CKD in populations based on eGFR equations [2,3]. These discussions aside, the ability to report or calculate eGFR has improved the identification of abnormalities of kidney function in persons around the world, and stimulated substantial research into the validation of the equations in different populations, and prediction models for progression to renal replacement . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?